Biotage AB Acquires Separtis Holding AG for 1.4M Euros (13M SEK) and Completes EU Distribution Consolidation
"It has always been within our plans to move from distributors to direct sales and service within our key European markets. This acquisition, in combination with other recent distributor changes in the EU, allows us to now service our critical markets directly while raising our operating margins," stated Jeff Bork, CEO of Biotage AB.
Dr. Reinhard Kupferschmidt, the current senior sales manager and technical director, will become the head of all Biotage business activities in Central and Eastern Europe. The existing Separtis business activities in Genzach-Wyhlen will continue as well.
"This substantially completes a crucial part of the Argonaut integration. For Biotage, it delivers critical skills and strong customer relationships in a vital EU region while providing the management talent necessary for our long term success," according to Dave Patteson, President of Biotage's Discovery Chemistry Business.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.